C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) G01N 33/53 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2496985
The present invention is directed to a method identifying a risk for a thrombogenic disorder including, without limitation, atrial fibrillation, stroke, prolonged intermitted neurological deficit (PRIND), transitory ischemic attack (TIA), atherosclerotic cerebrovascular disease (CVD) and/or coronary heart disease, as well as to a method for selecting patients with a risk for a thrombogenic disorder, to a method for identifying a pharmaceutical for the therapy or prophylaxis of a thrombogenic disorder as well as to a method for producing a medicament and a diagnostic by employing the TAFI-Ile347 polymorphism.
Deleuze Jean-Francois
Kozian Detlef
Mace Sandrine
Ricard Sylvain
Schaefer Stefan
Aventis Pharma Deutschland Gmbh
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Method for the identification of a risk for a thrombogenic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the identification of a risk for a thrombogenic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the identification of a risk for a thrombogenic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1991894